The brief

Analyst view

• Dexter is FDA-cleared for five common outpatient operations, from hernia repair to hysterectomy (2024-2026).
• Raised $150M in a Series G (Nov 2025) led by Revival Healthcare Capital, then a strategic investment from J&J (Jan 2026).
• Over 4,000 patients treated in Europe and the US by August 2026.

Technical approach

As reported

Small footprint

Robot that rolls between rooms

Compact mobile carts fit any operating room without modification, so a surgery centre can share one robot across rooms.

Open system

Uses the hospital's own kit

Works with third-party 3D cameras, energy devices and staplers instead of a closed ecosystem of proprietary tools.

Hybrid

Surgeon stays at the bedside

A sterile console sits beside the patient, so the surgeon can switch between robotic and ordinary laparoscopic instruments mid-case.